Auspex Pharmaceuticals, Inc. clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., May 5, 2015 · source ↗
The registry lists 5 studies whose lead sponsor is Auspex Pharmaceuticals, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 23, 2026.
- 5studies on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- 4
- First submitted after Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Auspex Pharmaceuticals, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- deutetrabenazine4 in phase 30 open · 5
All 5 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed5100%
Over the years
- 13
- 414
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Auspex Pharmaceuticals, Inc.5 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Teva Pharmaceutical Industries, Ltd. studies →
- Addressing Involuntary Movements in Tardive DyskinesiaCompletedNCT02291861Phase 3
Sponsor listed in the registry: Auspex Pharmaceuticals, Inc. · First submitted before Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- Reducing Involuntary Movements in Participants With Tardive DyskinesiaCompletedNCT02198794Phase 3
Sponsor listed in the registry: Auspex Pharmaceuticals, Inc. · First submitted before Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- Alternatives for Reducing Chorea in Huntington DiseaseCompletedNCT01897896Phase 3
Sponsor listed in the registry: Auspex Pharmaceuticals, Inc. · First submitted before Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)CompletedNCT02674321Phase 1
Sponsor listed in the registry: Auspex Pharmaceuticals, Inc. · First submitted after Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.
- Aim to Reduce Movements in Tardive DyskinesiaCompletedNCT02195700Phase 2/3
Sponsor listed in the registry: Auspex Pharmaceuticals, Inc. · First submitted before Auspex Pharmaceuticals, Inc. became part of Teva Pharmaceutical Industries, Ltd.